3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
113
Neoplasm Metastasis
5
Carcinoma, Intraductal, Noninfiltrating
5
Polycystic Ovary Syndrome
4
Ovarian Neoplasms
4
Osteoporosis
4
Neoplasms
4
Infertility
4
Breast Neoplasms, Male
4
Arthralgia
4
Fallopian Tube Neoplasms
3
Triple Negative Breast Neoplasms
2
Pain
2
Leiomyosarcoma
2
Leiomyoma
2
Endometrial Neoplasms
2
Cystadenocarcinoma, Serous
2
Breast Carcinoma In Situ
2
Bone Diseases, Metabolic
2
Advanced Breast Cancer
2
Uterine Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Cysts
1
Osteitis Deformans
1
Obesity
1
Multiple Endocrine Neoplasia Type 1
1
Medullary cystic kidney disease 1
1
Lymphoma, Non-Hodgkin
1
Interventions
Gemcitabine
4
130-nm albumin-bound paclitaxel
4
pembrolizumab
3
napabucasin
3
Paclitaxel
3
Irinotecan
3
selpercatinib
2
pralsetinib
2
patritumab
2
Standard of Care
2
Pemetrexed
2
Nivolumab
2
Fluorouracil
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Ascorbic Acid
2
Albumin-Bound Paclitaxel
2
valrubicin
1
sotorasib
1
ribociclib
1
relatlimab
1
pamiparib
1
osimertinib
1
ipatasertib
1
durvalumab
1
dostarlimab
1
cobimetinib
1
atezolizumab
1
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms by Site
×
Letrozole
×
Clear all
No trials found.